Biology Reference
In-Depth Information
Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, Masterman K-A, Maliszewski C, Shortman K,
Cebon J, Maraskovsky E (2002) Functionally distinct dendritic cell (DC) populations induced
by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC
subsets. Blood 100:1362-1372
Mano M, Arakawa T, Mano H, Nakagawa M, Kaneda T, Kaneko H, Yamada T, Miyata K,
Kiyomura H, Kumegawa M, Hakeda Y (2000) Prostaglandin E2 directly inhibits bone-resorb-
ing activity of isolated mature osteoclasts mainly through the EP4 receptor. Calcif Tissue Int
67:85-92
Miyamoto K-i, Waki Y, Horita T, Kasugai S, Ohya K (1997) Reduction of bone loss by denbufylline,
an inhibitor of phosphodiesterase 4. Biochem Pharmacol 54:613-617
Miyamoto K-i, Nishioka T, Waki Y, Nomura M, Katsuta H, Yokogawa K, Amano H (2006)
Phosphodiesterase 4 inhibitor rolipram potentiates the inhibitory effect of calcitonin on
osteoclastogenesis. J Bone Miner Metab 24:260-265
Monczor F, Fernandez N, Riveiro E, Mladovan A, Baldi A, Shayo C, Davio C (2006) Histamine
H2 receptor overexpression induces U937 cell differentiation despite triggered mechanisms to
attenuate cAMP signalling. Biochem Pharmacol 71:1219-1228
Morelli AE, Thomson AW (2003) Dendritic cells under the spell of prostaglandins. Trends
Immunol 24:108-111
Morita R, Ukyo N, Furuya M, Uchiyama T, Hori T (2003) Atrial natriuretic peptide polarizes
human dendritic cells toward a Th2-promoting phenotype through its receptor guanylyl
cyclase-coupled receptor A. J Immunol 170:5869-5875
Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev
Immunol 8:958-969
Nakashima T, Takayanagi H (2009) Osteoclasts and the immune system. J Bone Miner Metab
27:519-529
Noh ALSM, Yang M, Lee J-M, Park H, Lee D-S, Yim M (2009) Phosphodiesterase 3 and 4
negatively regulate receptor activator of nuclear factor-kappa B ligand-mediated osteoclast
formation by prostaglandin E2. Biol Pharm Bull 32:1844-1848
Nonaka T, Mio M, Doi M, Tasaka K (1992) Histamine-induced differentiation of HL-60 cells: the
role of cAMP and protein kinase A. Biochem Pharmacol 44:1115-1121
Novitskiy SV, Ryzhov S, Zaynagetdinov R, Goldstein AE, Huang Y, Tikhomirov OY, Blackburn
MR, Biaggioni I, Carbone DP, Feoktistov I, Dikov MM (2008) Adenosine receptors in
regulation of dendritic cell differentiation and function. Blood 112:1822-1831
Olsson IL, Breitman TR, Gallo RC (1982) Priming of human myeloid leukemic cell lines
HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine
3
0
:5
0
-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. Can-
cer Res 42:3928-3933
Ono K, Akatsu T, Murakami T, Nishikawa M, Yamamoto M, Kugai N, Motoyoshi K, Nagata N
(1998) Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell
formation from mouse bone marrow cells induced by PGE2. J Endocrinol 158:R1-R5
Ono K, Kaneko H, Choudhary S, Pilbeam CC, Lorenzo JA, Akatsu T, Kugai N, Raisz LG (2005)
Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the
EP2 receptor. J Bone Miner Res 20:23-29
Orenstein A, Kachel E, Zuloff-Shani A, Paz Y, Sarig O, Haik J, Smolinsky AK, Mohr R, Shinar E,
Danon D (2005) Treatment of deep sternal wound infections post-open heart surgery by
application of activated macrophage suspension. Wound Repair Regen 13:237-242
Paczesny S, Ueno H, Fay J, Banchereau J, Palucka AK (2003) Dendritic cells as vectors for
immunotherapy of cancer. Semin Cancer Biol 13:439-447
Park H, Yim M (2007) Rolipram, a phosphodiesterase 4 inhibitor, suppresses PGE2-induced osteo-
clast formation by lowering osteoclast progenitor cell viability. Arch Pharm Res 30:486-492
Park H, Young Lee S, Lee D-S, Yim M (2007) Phosphodiesterase 4 inhibitor regulates the
TRANCE/OPG ratio via COX-2 expression in a manner similar to PTH in osteoblasts.
Biochem Biophys Res Comm 354:178-183
